Europium(III) Complexes for Intracellular pH Sensing
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current pH sensors for intracellular applications face challenges such as photobleaching, autofluorescence, and limited sensitivity, particularly in monitoring acidic environments within living cells, where existing lanthanide-based probes are either not compatible with biological media or lack bioconjugation capabilities.
Innovation Solution
Development of Eu(III) complexes incorporating a 4-O-alkyl-3-N,N-dialkyl-arylethynylpyridine chromophore, which forms kinetically stable complexes and exhibits a significant change in luminescence emission intensity and lifetime over a pH range of 8 to 4, allowing for precise monitoring of acidification events in living cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If organic dye pH sensors (fluorescein, rhodamine, BODIPY) are used for intracellular pH monitoring, then the sensors can detect pH changes, but they suffer from photobleaching and autofluorescence that reduce measurement reliability
Solution Approach 1:
The patent transitions from organic dye-based sensors to europium(III) complex-based sensors, fundamentally changing the luminescent material parameter. This substitution eliminates photobleaching and autofluorescence issues while maintaining pH detection capability, as europium complexes exhibit different photophysical properties including longer emission lifetimes and resistance to photodegradation
Solution Approach 2:
The patent employs composite structures where europium(III) ions are coordinated with organic ligands containing arylethynylpyridine chromophores. This composite approach combines the stability and long emission lifetime of lanthanide ions with the pH-sensitive optical properties of organic chromophores, achieving both measurement precision and reliability
2Reliability
If existing lanthanide-based pH probes are used, then photobleaching is avoided, but they lack bioconjugation capabilities or compatibility with biological media
Solution Approach 1:
The patent designs europium(III) complex sensors that simultaneously provide multiple functions: pH detection through luminescence modulation, resistance to photobleaching inherent to lanthanide complexes, and bioconjugation capability through functional groups on the organic ligands. This multi-functionality allows the same probe to be used for various biological applications including cell imaging and intracellular pH monitoring
3Measurement precision
If conventional fluorophores are modified to tune pKa values, then pH sensitivity is improved, but the sensors still exhibit limited emission intensity change and modest switching ratios
Solution Approach 1:
The patent exploits the unique photophysical parameters of europium(III) ions, particularly their long emission lifetimes (hundreds of microseconds to milliseconds) compared to conventional fluorophores (nanoseconds). This parameter change enables time-resolved detection that eliminates autofluorescence background and achieves emission intensity variations exceeding two orders of magnitude upon acidification, far surpassing conventional fluorophore performance
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The Eu(III) complexes demonstrate a two-order magnitude change in emission intensity and lifetime, providing enhanced sensitivity and stability, enabling effective monitoring of pH changes in acidic cellular environments without photobleaching or autofluorescence issues, and allowing for bioconjugation to targeting vectors.
Implementation Method 1
whose luminescence emission is switched on by over two orders of magnitude during acidification
Implementation Method 2
europium(III) ion (Eu3+) and a compound of formula (I)... whose luminescence emission is switched on by over two orders of magnitude
Data Source
AI summary
The invention relates to a compound of formula (I) wherein R1; R2, R3 and R4 are as defined in the description. The invention also relates to europium (III) complexes obtained from a compound of formula (I), or from a complexing agent including said compound, and to the use of such complexes to label organic or biological molecules.